Blue Earth Therapeutics Ltd
2 clinical trials · Sponsor
◉ Watch Blue Earth Therapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer (NCT06516510) | Blue Earth Therapeutics Ltd | 2024-10-31 |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection (NCT05413850) | Blue Earth Therapeutics Ltd | 2022-07-20 |
Track Blue Earth Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.